现场笔记:莱索托艾滋病病毒感染者普遍治疗项目(检测与启动)实施后的初步结果,2015年10月至2017年2月
莱索托于2016年4月成为撒哈拉以南非洲首个采纳世界卫生组织(WHO)建议、对所有艾滋病病毒感染者无论CD4计数均启动抗病毒治疗(即「检测与启动」项目)的国家,并于2016年6月全国实施。本文报告该项目实施后的初步结果。
要点
- 莱索托2014年15-49岁人群艾滋病病毒感染率为24.6%,发病率为每100人年暴露1.9例新发感染。
- 2015年莱索托艾滋病病毒阳性者抗病毒治疗覆盖率为42%。
- 实施「检测与启动」前,许多感染者CD4计数<500个/mm3才符合治疗启动条件。
核心结论
- 莱索托于2016年4月成为撒哈拉以南非洲首个采纳WHO建议、对所有艾滋病病毒感染者无论CD4计数均启动抗病毒治疗(「检测与启动」项目)的国家,2016年6月全国实施。
研究设计与样本
- 本文为现场笔记,报告莱索托实施普遍治疗项目(「检测与启动」)后的初步结果。
主要发现
- 2014年莱索托15-49岁人群艾滋病病毒感染率为24.6%,发病率为每100人年暴露1.9例新发感染。
- 2015年莱索托艾滋病病毒阳性者抗病毒治疗覆盖率估计为42%。
- 实施「检测与启动」前,许多莱索托艾滋病病毒感染者CD4计数<500个/mm3才符合启动治疗条件。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lesotho, a small, mountainous country completely surrounded by the Republic of South Africa, has a population of approximately 2 million persons with an estimated gross national income of $1,280 per capita; 73% of the population resides in rural areas (1). Lesotho has a generalized human immunodeficiency virus (HIV) epidemic (2). In 2014, the prevalence of HIV infection among persons aged 15-49 years was 24.6%, with an incidence of 1.9 new infections per 100 person-years of exposure (3). As the leading cause of premature death, HIV/AIDS (acquired immunodeficiency syndrome) has contributed to Lesotho's reporting the shortest life expectancy at birth among 195 countries and territories (4). In 2015, antiretroviral therapy (ART) coverage among HIV-positive persons in Lesotho was estimated to be 42% (5). In April 2016, Lesotho became the first country in sub-Saharan Africa to adopt the World Health Organization (WHO) recommendations for universal initiation of antiretroviral therapy for all HIV-positive persons, regardless of CD4 count (known as the "Test and Start" program or approach), with nationwide implementation occurring in June 2016 (6,7). Before implementation of Test and Start, many persons living with HIV infection in Lesotho were not eligible to initiate treatment until their CD4 count was <500 cells/mm3.
引用
- Schwitters AM. Notes from the Field: Preliminary Results After Implementation of a Universal Treatment Program (Test and Start) for Persons Living with HIV Infection - Lesotho, October 2015-February 2017. MMWR Morb Mortal Wkly Rep. 2017. PMID: 28771456. doi:10.15585/mmwr.mm6630a4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。